When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
EDIT - 1 Promising Stock Down 66% That Could Skyrocket in 2024
Editas Medicine Inc.
2023-12-05 07:00:00 ET
Biotechs specializing in gene editing are making serious strides, but many are still clinical-stage companies. Their lack of consistent revenue and profits has been a turn-off for investors in recent years, which is why many of them have substantially lagged the market in this period.
That's the case with Editas Medicine (NASDAQ: EDIT) , a small-cap gene-editing specialist. However, Editas' shares have been rebounding this year and could maintain that momentum (and then some) well into 2024. Here's why.